Article
Integrated RNA and DNA sequencing improves mutation detection in low purity tumors
26 Jun 2014
Abstract excerpt
Identifying somatic mutations is critical for cancer genome characterization and for prioritizing patient treatment. DNA whole exome sequencing (DNA-WES) is currently the most popular technology; however, this yields low sensitivity in low purity tumors. RNA sequencing (RNA-seq) covers the expressed exome with depth proportional to expression. We hypothesized that integrating DNA-WES and RNA-seq would enable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
